{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:23:25Z","timestamp":1773883405096,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T00:00:00Z","timestamp":1502150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12185-017-2305-2","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T06:22:43Z","timestamp":1502173363000},"page":"852-859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy"],"prefix":"10.1007","volume":"106","author":[{"given":"Shin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norito","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"2305_CR1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","volume":"323","author":"GJ Anhalt","year":"1990","unstructured":"Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990;323:1729\u201335.","journal-title":"N Engl J Med"},{"key":"2305_CR2","first-page":"193","volume":"137","author":"VT Nguyen","year":"2001","unstructured":"Nguyen VT, Ndoye A, Bassler KD, Shults LD, Shields MC, Ruben BS, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol. 2001;137:193\u2013206.","journal-title":"Arch Dermatol"},{"key":"2305_CR3","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI115781","volume":"89","author":"JR Oursler","year":"1992","unstructured":"Oursler JR, Labib RS, Ariss-Abdo L, Burke T, O\u2019keefe EJ, Anhalt GJ, et al. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Investig. 1992;89:1775\u201382.","journal-title":"J Clin Investig"},{"key":"2305_CR4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/1523-1747.ep12607012","volume":"104","author":"T Hashimoto","year":"1995","unstructured":"Hashimoto T, Amagai M, Watanabe K, Chorzelski TP, Black MM, Stevens HP, et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Investig Dermatol. 1995;104:829\u201334.","journal-title":"J Investig Dermatol"},{"key":"2305_CR5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.det.2011.03.018","volume":"29","author":"JW Frew","year":"2011","unstructured":"Frew JW, Murrell DF. Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome). Dermatol Clin. 2011;29:419\u201325.","journal-title":"Dermatol Clin"},{"key":"2305_CR6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","volume":"148","author":"S Leger","year":"2012","unstructured":"Leger S, Picard D, Ingen-Housz-Oro S, Arnault JP, Aubin F, Carsuzaa F, et al. Prognostic factors of paraneoplastic pemphigus. Arch Dermatol. 2012;148:1165\u201372.","journal-title":"Arch Dermatol"},{"key":"2305_CR7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2174\/1871520615666150716105425","volume":"15","author":"A Animesh","year":"2015","unstructured":"Animesh A. Paraneoplastic pemphigus: autoimmune-cancer nexus in the skin. Anticancer Agents Med Chem. 2015;15:1215\u201323.","journal-title":"Anticancer Agents Med Chem"},{"key":"2305_CR8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-4632.2009.03995.x","volume":"48","author":"VN Sehgal","year":"2009","unstructured":"Sehgal VN, Srivastava G. Paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome. Int J Dermatol. 2009;48:162\u20139.","journal-title":"Int J Dermatol"},{"key":"2305_CR9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199905063401805","volume":"340","author":"HC Nousari","year":"1999","unstructured":"Nousari HC, Deterding R, Wojtczack H, Aho S, Uitto J, Hashimoto T, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med. 1999;340:1406\u201310.","journal-title":"N Engl J Med"},{"key":"2305_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1843.2008.01397.x","volume":"14","author":"F Maldonado","year":"2009","unstructured":"Maldonado F, Pittelkow MR, Ryu JH. Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome. Respirology. 2009;14:129\u201333.","journal-title":"Respirology"},{"key":"2305_CR11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2133.2003.05659.x","volume":"149","author":"OV Nikolskaia","year":"2003","unstructured":"Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman\u2019s disease. Br J Dermatol. 2003;149:1143\u201351.","journal-title":"Br J Dermatol"},{"key":"2305_CR12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","volume":"43","author":"P Joly","year":"2000","unstructured":"Joly P, Richard C, Gilbert D, Couville P, Chosidow O, Roujeau JC, et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol. 2000;43:619\u201326.","journal-title":"J Am Acad Dermatol"},{"key":"2305_CR13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","volume":"44","author":"KC Meyer","year":"2014","unstructured":"Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, et al. An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir J. 2014;44:1479\u2013503.","journal-title":"Eur Respir J"},{"key":"2305_CR14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(03)14110-4","volume":"362","author":"KM Anderson","year":"2003","unstructured":"Anderson KM, Smith P, Norton A, Hancock BW, Hoskin PJ, MacLennan KA, et al. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomized controlled trial. Lancet. 2003;362:516\u201322.","journal-title":"Lancet"},{"key":"2305_CR15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","volume":"15","author":"P Brice","year":"1997","unstructured":"Brice P, Bastion Y, Lepage E, Brousse N, Haioun C, Moreau P, et al. Comparison in low-tomor-burden follicular lymphoma between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Group d\u2019Etude des Lymphomes Folliculares. J Clin Oncol. 1997;15:1110\u20137.","journal-title":"J Clin Oncol"},{"key":"2305_CR16","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.1998.16.7.2332","volume":"16","author":"P Solal-Celigny","year":"1998","unstructured":"Solal-Celigny P, Lepage E, Brousse N, Tendler CL, Brice P, Haioun C, et al. Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Group d\u2019Etude des Lymphomes Folliculares 86 trial. J Clin Oncol. 1998;16:2332\u20138.","journal-title":"J Clin Oncol"},{"key":"2305_CR17","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","volume":"173","author":"A Ohzono","year":"2015","unstructured":"Ohzono A, Sogame R, Li X, Teye K, Tsuchiasaka A, Numata S, et al. Clinical immunological findings in 104 cases of paraneoplastic pemphigus. Br J Dermatol. 2015;173:1447\u201352.","journal-title":"Br J Dermatol"},{"key":"2305_CR18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2003.09.020","volume":"40","author":"I Kaplan","year":"2004","unstructured":"Kaplan I, Hodak E, Ackerman L, Mimouni D, Calderon S. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol. 2004;40:553\u201362.","journal-title":"Oral Oncol"},{"key":"2305_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3960\/jslrt.55.83","volume":"55","author":"T Hirano","year":"2015","unstructured":"Hirano T, Higuchi Y, Yuki H, Hirata S, Nosaka K, Ishii N, et al. Rituximab monotherapy and rituximab-containing chemotherapy were effective for paraneoplastic pemphigus accompanying follicular lymphoma, but not for subsequent bronchiolitis obliterans. J Clin Exp Hematol. 2015;55:83\u20138.","journal-title":"J Clin Exp Hematol"},{"key":"2305_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM200307243490421","volume":"349","author":"MA Hoffman","year":"2003","unstructured":"Hoffman MA, Qiao X, Anhalt GJ. CD8+ T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman\u2019s disease. N Engl J Med. 2003;349:407\u20138.","journal-title":"N Engl J Med"},{"key":"2305_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3348\/kjr.2006.7.1.57","volume":"7","author":"JM Chang","year":"2006","unstructured":"Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, et al. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006;7:57\u20139.","journal-title":"Korean J Radiol"},{"key":"2305_CR22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200201-003PP","volume":"16","author":"M Estenne","year":"2002","unstructured":"Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care. 2002;16:440\u20134.","journal-title":"Am J Respir Crit Care"},{"key":"2305_CR23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00259-006-0073-y","volume":"33","author":"U Tateishi","year":"2006","unstructured":"Tateishi U, Hasegawa T, Terauchi T, Moriyama N, Arai Y. Disease activity and 18F-FDG uptake in organizing pneumonia: semi-quantitative evaluation using computed tomography and position emission tomography. Eur J Nucl Med Mol Imaging. 2006;33:906\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2305_CR24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1378\/chest.117.2.603","volume":"117","author":"M Takahashi","year":"2000","unstructured":"Takahashi M, Shimatsu Y, Kazama T, Kimura K, Otuka T, Hashimoto T, et al. Paraneoplastic pemphigus associated with bronchiolitis obliterans. Chest. 2000;117:603\u20137.","journal-title":"Chest"},{"key":"2305_CR25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1183\/09031936.04.00023204","volume":"24","author":"VS Gudi","year":"2004","unstructured":"Gudi VS, Ormerod AD, Weir J, Kerr KM, Devereux G. Severe breathlessness, mouth ulcers and skin blistering in a female. Eur Respir J. 2004;24:884\u20137.","journal-title":"Eur Respir J"},{"key":"2305_CR26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0929-6646(08)60038-8","volume":"106","author":"SH Wang","year":"2007","unstructured":"Wang SH, Chu CY, Chen HH, Chang YL, Chen KY, Chiu HC, et al. Paraneoplastic pemphigus and bronchiolitis obliterans in a patient with splenic B-cell lymphoma. J Formos Med Assoc. 2007;106:768\u201373.","journal-title":"J Formos Med Assoc"},{"key":"2305_CR27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/1346-8138.12021","volume":"40","author":"KY Park","year":"2013","unstructured":"Park KY, Choi SY, Seo SJ, Hong CK. Case or paraneoplastic pemphigus associated with retroperitoneal diffuse large B-cell lymphoma and fetal bronchiolitis obliterans-like lung disease. J Dermatol. 2013;40:142\u20134.","journal-title":"J Dermatol"},{"key":"2305_CR28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/1346-8138.12521","volume":"41","author":"M Kanaoka","year":"2014","unstructured":"Kanaoka M, Matsukura S, Ishikawa H, Matsuura M, Ishii N, Hashimoto T, et al. Paraneoplastic pemphigus associated with fetal bronchiolitis obliterans and appearance of anti-BP180 antibodies in the late stage of the disease. J Dermatol. 2014;41:628\u201330.","journal-title":"J Dermatol"},{"key":"2305_CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000357109","volume":"132","author":"K Morikawa","year":"2014","unstructured":"Morikawa K, Tsuji T, Yamasaka H, Egashira S, Kaguchi A, Kido M, et al. Paraneoplastic pemphigus occurs most commonly in indolent B call lymphoma. Acta Haematol. 2014;132:73\u20134.","journal-title":"Acta Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-017-2305-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T17:30:57Z","timestamp":1510767057000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-017-2305-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2305"],"URL":"https:\/\/doi.org\/10.1007\/s12185-017-2305-2","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,8]]}}}